What Artia Solutions does

Artia Solutions is a Tallahassee, Florida-based Medicaid pharmaceutical consulting firm founded in 2005 by George Kitchens, RPh, after his tenure as Florida Medicaid pharmacy director. The company provides specialized services to drug manufacturers across the full Medicaid access lifecycle, including drug launch strategy, supplemental rebate negotiation, financial modeling, product monitoring, account management, and legislative/policy strategy. Its client base spans specialty manufacturers (e.g., ParaPRO, RedHill Biopharma, Aurinia, Neurocrine, Spark Therapeutics) to large-cap pharma (e.g., Teva Pharmaceuticals, Pierre Fabre). The firm claims to have launched over 46% of all drugs approved in the U.S. in 2025.\n\nThe company's core technology stack includes four proprietary products: The App (iOS/Android mobile application for P&T and DUR meeting tracking and market share data across all states), Capsule (proprietary state-specific Medicaid coverage and policy database), Artia Alerts (daily notifications on FFS and MMC pharmacy website changes), and Advantage+ (subscription legislative and policy tracking service with monthly newsletter, webinars, and legislative tracker). In 2026, Artia launched GENEROUS Navigator, a platform for navigating the CMS GENEROUS Model with predictive rebate modeling. The firm also hosts the biennial Crossroads conference in Nashville (740+ attendees in 2025) and monthly Advantage+ webinars.\n\nArtia Solutions operates a professional services model with custom engagement-based pricing and multi-year contracts, positioning itself as either an extension of the client's market access team or a full outsourced market access function. The company was acquired by Petauri, a purpose-built pharmaceutical services platform backed by Oak Hill Capital, in July 2025 and now operates as one of six business units within the Petauri platform. With over 40 employees including PharmDs and former Medicaid officials, Artia combines deep regulatory expertise with proprietary technology to serve pharmaceutical manufacturers navigating complex state and federal Medicaid policy environments.

Name

Artia Solutions

Legal name

Artia Solutions, LLC

Website

https://artiasolutions.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Artia Solutions is a Tallahassee-based Medicaid pharmaceutical consulting firm serving drug manufacturers with launch strategy, supplemental rebate negotiation, and policy tracking. It combines proprietary technology (Capsule database, The App, Advantage+, GENEROUS Navigator) with consulting, operating as a Petauri business unit since July 2025.

Ownership category

akta.pro rank

Headquarters

HQ city

Flushing

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Medicaid Access Consulting Services: Professional consulting services for drug manufacturers including Medicaid drug launch strategy, supplemental rebate negotiations, product monitoring, account management, and legislative/policy strategy. Services are tailored to client needs ranging from specific deliverables to full market access team augmentation.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Artia Solutions is a Medicaid-focused consulting firm that helps pharmaceutical manufacturers develop drug launch strategies, negotiate supplemental rebates, and navigate state and federal Medicaid policies for prescription drug access. It pairs professional consulting services with proprietary technology tools, including the Capsule database, The App, Artia Alerts, Advantage+, and the GENEROUS Navigator platform, to forecast access, monitor coverage landscapes, and support post-launch product management.

Product overview

Artia Solutions is a Medicaid-focused pharmaceutical consulting firm offering a proprietary technology platform integrated with consulting services. The product portfolio centers on four core technology products—The App (mobile application for iOS/Android), Capsule (proprietary state-specific Medicaid database), Artia Alerts (daily notification service), and Advantage+ (legislative/policy tracking subscription)—supplemented by specialized consulting services for Medicaid drug launch strategy, financial modeling and analysis, product monitoring and account management, and legislative and policy strategy. The company also hosts the biennial Crossroads Conference and developed GENEROUS Navigator, a specialized platform for navigating CMS GENEROUS Model requirements. Artia Solutions was acquired by Petauri in July 2025 and now operates as part of the Petauri pharmaceutical-services platform.

Differentiator

Problem solved

Functional benefit

Brands

• Capsule: Proprietary database that houses state-specific Medicaid information for pharmaceutical manufacturers. It monitors the most up-to-date coverage and policy information for access strategies and business decisions.
• Advantage+
• Artia Alerts
• The Artia App
• Crossroads Conference

Products and services

• Medicaid Drug Launch Strategy Strategic consulting service that helps pharmaceutical manufacturers develop Medicaid access strategies, predict access levels before launch, define coverage requirements, identify barriers, calculate supplemental rebating, and develop clinical messaging through decision-maker meetings.
• Financial Modeling & Analysis Analytical consulting service providing in-depth PDL category review to support bid participation decisions, rebate structure optimization, bid submission, competitor net cost forecasting, price increase impact analysis, and Medicaid gross-to-net ROI modeling.
• Product Monitoring & Account Management Post-launch consulting service that tracks product/class status, PDL updates, P&T/DUR meeting information, market share data, and provides account management through Medicaid program engagement opportunities.

Quantifiable outcome

• 46% of all drugs approved in the U.S. in 2025 were launched by Artia Solutions
• +1 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Mtech Access: A Petauri-acquired UK- and global-focused market access consultancy; highly comparable service model (payer strategy, HTA support, policy advisory) and now shares corporate parentage with Artia post-Petauri integration.
• Xcenda: Part of Cencora (formerly AmerisourceBergen), Xcenda is one of the largest market access and health economics consulting firms serving pharmaceutical manufacturers, with deep Medicaid and payer strategy capabilities directly comparable to Artia's core service line.
• Avalere Health: A health policy and market access consultancy with a strong Medicaid practice serving pharma manufacturers, payers, and providers; overlaps with Artia on policy advisory, supplemental rebate strategy, and state Medicaid navigation.
• Precision Medicine Group: Specialized services platform offering market access, HEOR, and medical affairs consulting to pharma manufacturers; competes with Artia for mid-tier and large pharma market access engagements.
• Petauri MAx: Internal Petauri business unit focused on market access excellence; sister to Artia under the same Oak Hill Capital-backed platform and serving overlapping pharma manufacturer customers with adjacent offerings.
• Dymaxium: Drug pricing analytics and formulary/PDL data provider serving pharma manufacturers; most directly comparable to Artia's Capsule database and Artia Alerts products as a competing technology-enabled market access vendor.
• EVERSANA: Large-scale pharma services platform offering market access, patient services, and commercial strategy; competes with Artia for manufacturer market access budgets and has invested heavily in Medicaid and policy advisory capabilities.
• Formulary Insights: Petauri sister business unit focused on formulary and P&T committee support for pharma; addresses an adjacent Medicaid access workflow and shares the same Oak Hill Capital-backed parent as Artia.
• The Kinetix Group: A Petauri sister business unit focused on market access, payer engagement, and health system activation for pharma; now part of the same parent platform as Artia, addressing adjacent rather than identical Medicaid policy work.

Broad incumbents

• Charles River Associates (Life Sciences Practice): Global management consultancy with a sizable life sciences practice advising pharma on commercial, pricing, and market access strategy; competes with Artia for larger strategic engagements though it does not specialize in Medicaid policy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCiUEW6mjf0jCfPVPHFYePUw
• LinkedInlinkedin.com/company/artia-solutions
• Instagraminstagram.com/artiasolutions
• Xx.com/artiasolutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Artia Solutions